Market access strategies for medical devices
In the latest Global Medical Device podcast episode, Etienne Nichols is joined by Shaherah Yancy, CEO of Research Lifecycle Solutions. They dive deep into the critical importance of developing robust clinical and regulatory strategies for MedTech companies. Shaherah shares her extensive experience in the field, providing practical advice on securing funding, ensuring market access, and achieving market adoption. They also explore the nuances of clinical evidence, the significance of strategic planning, and the role of advisory panels in navigating the MedTech landscape. Listen to the full episode to gain valuable insights from one of the leading experts in the field. Don’t miss out on this opportunity to learn from Shaherah’s wealth of knowledge. Tune in: Clinical Evidence: The Key to Market Adoption (greenlight.guru)
Why is clinical evidence important?
- Strategic Planning is Essential: Early and comprehensive planning for clinical and regulatory strategies can significantly enhance a company’s chances of success.
- Clinical Evidence is Critical: Collecting robust clinical data is vital for both market access and long-term market adoption.
- Market Adoption Over Market Access: The ultimate goal should be market adoption, not just getting to market.
Memorable quotes from this episode
- “Market access is a milestone. Market adoption is the goal.” – Shaherah Yancy
- “Understanding the problem you’re solving is crucial for your strategy.” – Shaherah Yancy
- “Don’t be afraid of clinical evidence; it’s your key to success.” – Shaherah Yancy
Key timestamps
- 00:00 – 03:00 Introduction and Sponsor Message
- 03:01 – 05:20 Introduction to Shaherah Yancy and her background
- 05:21 – 10:30 Importance of Clinical and Regulatory Strategies
- 10:31 – 17:15 Challenges of Securing Funding and Developing Strategy
- 17:16 – 25:45 Differences Between Market Access and Market Adoption
- 25:46 – 33:50 Developing Effective Clinical Plans for Market Adoption
- 33:51 – 39:40 Importance of Evidence and Study Design
- 39:41 – 48:00 Examples and Case Studies from Early Stage Companies
- 48:01 – 55:15 Endpoints for Market Adoption
- 55:16 – 01:02:30 Strategies for Novel Technologies
- 01:02:31 – 01:07:45 Final Advice and Contact Information